Molecular and cellular aspects of allergic conjunctivitis

Chemical Immunology

Volumn 73, Issue , 1999, Pages 39-58

  Liu, Grace ^a   Keane Myers, Andrea ^a   Miyazaki, Dai ^a   Tai, Albert ^a   Ono, Santa J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CYTOKINE;

ALLERGIC CONJUNCTIVITIS; CELLULAR IMMUNITY; HUMAN; MAST CELL; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 0032854385     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: 10.1159/000058748     Document Type: Review

References (29)

1. King T: Chemical and biological properties of some atopic allergens. Adv Immunol 1976;23:77-105.
2. Friedlaender MH: Immunologic aspects of diseases of the eye. JAMA 1992;268:2869-2873.
3. Marsh D, Bias W, Ishizaka K: Genetic control of basal serum IgE level and its effect on specific reagenic sensitivity. Proc Natl Acad Sci USA 1974;71:3588-3592.
4. Gerrard J, Rao D, Morton N: A genetic study of immunoglobulin E. Am J Hum Genet 1978;20:46-58.
5. Ono SJ: Transcriptional regulation of the genes of the human major histocompatibility complex; in Chicz, R, Urban R (eds): The Major Histocompatibility Complex. Austin, Landes, 1995.
6. Marsh D, Neely J, Breazeale D, Ghosh B, Friedhoff L, Errlich-Kautzky E, Schou C, Krishnaswamy G, Beaty T: Linkage analysis of IL-4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 1994;264:1152-1156.
7. Meyers D, Postma D, Panhuysen C, Amelung P, Levitt R, Bleecker E: Evidence for a locus regulating total serum IgE levels mapping of chromosome 5. Genomics 1994;26:464-470.
8. Casolaro V, Georas S, Ono SJ: Regulation of interleukin-4 synthesis. Int J Immunopathol Pharm 1997;10:1-5.
9. Ono SJ: Molecular genetics of IgE-mediated inflammation. J Allergy (in press).
10. Hahn L, Cornell-Bell A, Martin-Ellis C, Allansmith M: Conjunctival basophil hypersensitivity lesions in guinea pigs. Invest Ophthalmol Vis Sci 1986;27:1255-1260.
11. Trocme S, Trocme M, Bloch K, Allansmith M: Topically induced ocular anaphylaxis in rats immunized with egg albumin. Ophthalmic Res 1986;18:68-74.
12. Barney N, Kleinman R, Trocme S, Bloch K, Allansmith M: Attenuation of rat conjunctival response by repeated hapten applications. Curr Eye Res 1988;7:843-848.
13. Greiner J, Peace D, Baird R, Allansmith M: Effects of eye rubbing on the conjunctiva as a model of ocular inflammation. Am J Ophthamol 1985;100:45-50.
14. Germann T, Szeliga J, Hess H, Storkel S, Podlaski F, Gately M, Schmitt E, Rude E: Administration of interleukin-12 in combination with type II collagen induces severe arthritis in DBA/1 mice. Proc Natl Acad Sci USA 1995;92:4823-4827.
15. Trinchieri G: Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995;13:251-276.
16. Mauri C, Williams RO, Walmsley M, Feldmann M: Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur J Immunol 1996;26:1511-1518.
17. Fukushima H, Yoshida H, Iwamoto O, Yoshida O, Ueno H: The role of cellular immunity both in the induction and effector phases of experimental allergic blepharoconjunctivis in rats. Exp Eye Res 1997;65:631-637.
18. Allansmith M, Baird R, Barney N, Ross R, Bloch K: Determination of the interval during which one application of compound 48/80 to the rat conjunctiva influences the response to a second application. Ophthalmic Res 1990;22:137-143.
19. Abelson M, Allansmith M, Friedlander M: Effects of topically applied ocular decongestants and antihistamines. Am J Ophthalmol 1980;90:254-257.
20. Udell I, Abelson M: Animal and human ocular surface response to a topical nonimmune mast cell degranulating agent (compound 48/80). Am J Ophthalmol 1981;91:226-230.
21. Merayo-Lloves J, Calonge M, Foster CS: Experimental model of allergic conjunctivitis to ragweed in guinea pig. Curr Eye Res 1995;14:487-494.
22. Dwyer R StC, Turk J, Darougar S: Immediate hypersensitivity in the guinea pig conjunctiva. I. Characterization of the IgE and IgG1 antibodies involved. Int Arch Allergy Appl Immunol 1974;46:910-924.
23. Saiga T, Briggs R, Allansmith M: Clinical and cytologic aspects of ocular late-phase reaction in the guinea pig. Ophthalmic Res 1992;24:45-50.
24. Merayo-Lloves J, Zhao TZ, Dutt J, Foster CS: A new murine model of allergic conjunctivitis and effectiveness of nedocromil sodium. J Allergy Clin Immunol 1996;97:1129-1140.
25. Magone MT, Chan CC, Rizzo L, Kozhich A, Whitcup S: A novel murine model of allergic conjunctivitis. Clin Immunol Immunopathol 1998;87:75-84.
26. Keane-Meyers A, Cheung-Chau KW, Bond J, Ono SJ: Th2 cytokines influence both the early and late phase reactions in an experimental model of allergic conjunctivitis (submitted).
27. Allansmith M, Baird R, Ross R: Morphologic evidence that compound 48/80-challenged rat eyelid mast cells differ in their states of maximal degranulation. Ophthalmic Res 1989;21:206-215.
28. Allansmith M, Baird R, Barney N, Ross R, Bloch K: Response of rat conjunctival mast cells to multiple versus single applications of compond 48/80. Ophthalmic Res 1989;21:392-400.
29. Abelson M, Butrus S, Kliman G, Larson D, Corey EJ, Smith L: Topical arachidonic acid: A model for screening anti-inflammatory agents. J Ocul Pharmacol 1987;3:63-75.